|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.58 EUR | +0.41% |
|
+0.49% | -2.54% |
| Apr. 17 | French and Benelux stocks-Factors to watch April 17 | RE |
| Apr. 16 | Coty and Interparfums deny report of talks regarding Boss, Burberry perfume licenses | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.76 | 9.55 | 10.58 | 11.12 | 10.52 | |||||
Return on Total Capital | 10.66 | 12.14 | 13.47 | 13.67 | 12.66 | |||||
Return On Equity % | 13.82 | 17.61 | 19.33 | 19.41 | 17.76 | |||||
Return on Common Equity | 13.75 | 17.55 | 19.25 | 19.41 | 17.74 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 65.52 | 67.21 | 66.1 | 66.14 | 64.99 | |||||
SG&A Margin | 46.87 | 47.12 | 45.5 | 45.47 | 45.07 | |||||
EBITDA Margin % | 18.61 | 21.78 | 22.98 | 21.55 | 21.37 | |||||
EBITA Margin % | 18.18 | 19.78 | 20.91 | 20.4 | 20.5 | |||||
EBIT Margin % | 17.99 | 19.57 | 20.73 | 20.22 | 19.48 | |||||
Income From Continuing Operations Margin % | 12.78 | 14.18 | 14.99 | 14.8 | 14.12 | |||||
Net Income Margin % | 12.68 | 14.08 | 14.87 | 14.75 | 14.07 | |||||
Net Avail. For Common Margin % | 12.68 | 14.08 | 14.87 | 14.75 | 14.07 | |||||
Normalized Net Income Margin | 11.41 | 12.27 | 12.69 | 12.35 | 11.54 | |||||
Levered Free Cash Flow Margin | -12.76 | 4.54 | 5.28 | 10.86 | 8.71 | |||||
Unlevered Free Cash Flow Margin | -12.51 | 4.25 | 5.85 | 11.46 | 9.17 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.78 | 0.78 | 0.82 | 0.88 | 0.86 | |||||
Fixed Assets Turnover | 6.82 | 4.66 | 4.94 | 5.5 | 6.15 | |||||
Receivables Turnover (Average Receivables) | 5.31 | 5.35 | 5.74 | 5.8 | 5.41 | |||||
Inventory Turnover (Average Inventory) | 1.99 | 1.81 | 1.52 | 1.38 | 1.47 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.19 | 2.26 | 2.7 | 2.76 | 2.95 | |||||
Quick Ratio | 1.96 | 1.29 | 1.47 | 1.65 | 1.92 | |||||
Operating Cash Flow to Current Liabilities | 0.49 | 0.32 | 0.43 | 0.5 | 0.74 | |||||
Days Sales Outstanding (Average Receivables) | 68.79 | 68.27 | 63.62 | 63.11 | 67.51 | |||||
Days Outstanding Inventory (Average Inventory) | 183.73 | 201.34 | 239.94 | 265.24 | 247.49 | |||||
Average Days Payable Outstanding | 128.96 | 132.44 | 127.86 | 121.4 | 130.45 | |||||
Cash Conversion Cycle (Average Days) | 123.56 | 137.17 | 175.71 | 206.95 | 184.55 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 23.09 | 26.9 | 21.46 | 21.11 | 20.81 | |||||
Total Debt / Total Capital | 18.76 | 21.2 | 17.67 | 17.43 | 17.23 | |||||
LT Debt/Equity | 20.11 | 22.37 | 17.21 | 15.28 | 14.21 | |||||
Long-Term Debt / Total Capital | 16.34 | 17.63 | 14.17 | 12.62 | 11.76 | |||||
Total Liabilities / Total Assets | 33.9 | 39.81 | 33.52 | 32.37 | 30.27 | |||||
EBIT / Interest Expense | 44.6 | -42.38 | 22.41 | 21.38 | 26.59 | |||||
EBITDA / Interest Expense | 49.14 | -48.2 | 25.22 | 23.16 | 29.64 | |||||
(EBITDA - Capex) / Interest Expense | -2.48 | -40.11 | 24.2 | 22.84 | 26.83 | |||||
Total Debt / EBITDA | 1.13 | 1.02 | 0.74 | 0.76 | 0.78 | |||||
Net Debt / EBITDA | -0.48 | 0.03 | -0.04 | -0.22 | -0.27 | |||||
Total Debt / (EBITDA - Capex) | -22.34 | 1.22 | 0.77 | 0.78 | 0.86 | |||||
Net Debt / (EBITDA - Capex) | 9.42 | 0.04 | -0.05 | -0.23 | -0.29 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 52.66 | 26 | 13 | 10.27 | 2.15 | |||||
Gross Profit, 1 Yr. Growth % | 60.73 | 29.24 | 11.14 | 10.33 | 0.38 | |||||
EBITDA, 1 Yr. Growth % | 58.61 | 36.95 | 10.88 | 0.94 | -4.16 | |||||
EBITA, 1 Yr. Growth % | 117.41 | 38.54 | 20.73 | 8.48 | 3.57 | |||||
EBIT, 1 Yr. Growth % | 115.05 | 37.11 | 19.7 | 7.54 | -1.58 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 131.09 | 39.76 | 19.46 | 8.87 | -2.5 | |||||
Net Income, 1 Yr. Growth % | 131.55 | 39.99 | 19.31 | 9.37 | -2.54 | |||||
Normalized Net Income, 1 Yr. Growth % | 123.91 | 35.42 | 16.9 | 7.33 | -4.54 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 126.97 | 47.41 | 25.54 | 15.06 | 2.23 | |||||
Accounts Receivable, 1 Yr. Growth % | 45.92 | 10.74 | 0.4 | 17.75 | 2.62 | |||||
Inventory, 1 Yr. Growth % | 10.39 | 50.26 | 31.88 | 13.51 | -14.15 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 560.19 | 12.29 | 1.55 | -3.67 | -0.95 | |||||
Total Assets, 1 Yr. Growth % | 33.27 | 20.16 | -2 | 6.69 | 1.59 | |||||
Tangible Book Value, 1 Yr. Growth % | 15.56 | -7.86 | 12.45 | 12.53 | 4.81 | |||||
Common Equity, 1 Yr. Growth % | 9.93 | 9.43 | 8.19 | 8.74 | 4.73 | |||||
Cash From Operations, 1 Yr. Growth % | 67.78 | 2.14 | 7.22 | 27.45 | 39.28 | |||||
Capital Expenditures, 1 Yr. Growth % | 1.27K | -77.39 | -71.44 | -64.42 | 591.02 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -266.76 | -144.42 | 9.24 | 132.69 | -18.08 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -261.35 | -142.35 | 27.99 | 115.81 | -18.23 | |||||
Dividend Per Share, 1 Yr. Growth % | 87.99 | 22.88 | 20.47 | 0 | 10.48 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.62 | 38.69 | 19.32 | 11.63 | 6.13 | |||||
Gross Profit, 2 Yr. CAGR % | 8.47 | 44.13 | 19.85 | 10.73 | 5.24 | |||||
EBITDA, 2 Yr. CAGR % | 8.68 | 52.92 | 27.79 | 7.07 | 1.11 | |||||
EBITA, 2 Yr. CAGR % | 18.14 | 72.6 | 28.66 | 13.95 | 5.54 | |||||
EBIT, 2 Yr. CAGR % | 17.5 | 71.71 | 28.11 | 13.46 | 2.88 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.44 | 79.71 | 29.21 | 14.04 | 3.03 | |||||
Net Income, 2 Yr. CAGR % | 18.5 | 80.04 | 29.24 | 14.23 | 3.24 | |||||
Normalized Net Income, 2 Yr. CAGR % | 18.92 | 74.13 | 25.82 | 12.01 | 1.22 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 19.05 | 78.38 | 32.68 | 17.18 | 5.74 | |||||
Accounts Receivable, 2 Yr. CAGR % | 15.7 | 27.12 | 5.44 | 8.73 | 9.92 | |||||
Inventory, 2 Yr. CAGR % | -2.06 | 28.79 | 40.77 | 22.35 | -1.28 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 180.85 | 172.28 | 6.79 | -1.09 | -5.51 | |||||
Total Assets, 2 Yr. CAGR % | 16.95 | 26.56 | 8.51 | 2.25 | 4.11 | |||||
Tangible Book Value, 2 Yr. CAGR % | 12.79 | 3.19 | 1.79 | 12.49 | 8.6 | |||||
Common Equity, 2 Yr. CAGR % | 8.16 | 9.68 | 8.81 | 8.47 | 6.72 | |||||
Cash From Operations, 2 Yr. CAGR % | 24.9 | 30.91 | 4.65 | 16.9 | 33.24 | |||||
Capital Expenditures, 2 Yr. CAGR % | 507.88 | 75.81 | -74.59 | -68.12 | 56.81 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 165.51 | -13.56 | -23.61 | 57.51 | 38.06 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 173.15 | -16.9 | -18.81 | 66.2 | 32.84 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 51.99 | 21.67 | 9.77 | 5.1 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.19 | 13.42 | 29.54 | 16.22 | 8.37 | |||||
Gross Profit, 3 Yr. CAGR % | 7.38 | 15 | 32.17 | 16.59 | 7.17 | |||||
EBITDA, 3 Yr. CAGR % | 11.32 | 20.31 | 40.75 | 19.08 | 5.11 | |||||
EBITA, 3 Yr. CAGR % | 15.5 | 24.13 | 52.69 | 21.2 | 10.06 | |||||
EBIT, 3 Yr. CAGR % | 15.08 | 23.7 | 52.25 | 20.85 | 8.21 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 14.57 | 25.16 | 56.84 | 22.04 | 8.24 | |||||
Net Income, 3 Yr. CAGR % | 14.67 | 25.26 | 56.97 | 22.24 | 8.34 | |||||
Normalized Net Income, 3 Yr. CAGR % | 15.34 | 24.19 | 52.47 | 19.33 | 6.2 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.96 | 25.72 | 56.05 | 24.41 | 10.09 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.96 | 14.02 | 17.5 | 9.39 | 6.65 | |||||
Inventory, 3 Yr. CAGR % | 0.47 | 12.96 | 29.81 | 31.02 | 8.72 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 180.22 | 106.9 | 95.99 | 3.18 | -3.21 | |||||
Total Assets, 3 Yr. CAGR % | 11.26 | 18.02 | 16.22 | 7.9 | 2.03 | |||||
Tangible Book Value, 3 Yr. CAGR % | 10.69 | 5.44 | 6.19 | 5.25 | 9.87 | |||||
Common Equity, 3 Yr. CAGR % | 6.79 | 8.58 | 9.18 | 8.79 | 7.21 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.76 | 16.8 | 22.48 | 11.76 | 23.93 | |||||
Capital Expenditures, 3 Yr. CAGR % | 261.92 | 102.92 | -4.08 | -71.57 | -11.12 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 20.49 | 46.72 | -0.62 | 9.84 | 26.67 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 19 | 47.25 | 2.44 | 12.47 | 31.21 | |||||
Dividend Per Share, 3 Yr. CAGR % | 20.78 | - | 40.66 | 13.97 | 10 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.93 | 10.86 | 11.89 | 12.7 | 19.61 | |||||
Gross Profit, 5 Yr. CAGR % | 8.97 | 11.19 | 12.21 | 13.27 | 20.65 | |||||
EBITDA, 5 Yr. CAGR % | 11.67 | 18.21 | 19.39 | 16.51 | 23.9 | |||||
EBITA, 5 Yr. CAGR % | 15.61 | 18.41 | 20.33 | 19.71 | 31.49 | |||||
EBIT, 5 Yr. CAGR % | 15.36 | 18.17 | 20.13 | 19.5 | 30.16 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.88 | 19.79 | 20.22 | 20.59 | 32.57 | |||||
Net Income, 5 Yr. CAGR % | 16.99 | 20.02 | 20.29 | 20.73 | 32.75 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.7 | 19.29 | 19.43 | 19.17 | 29.43 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 15.49 | 20.28 | 20.53 | 21.02 | 32.21 | |||||
Accounts Receivable, 5 Yr. CAGR % | 10.36 | 12.91 | 8.72 | 11.87 | 14.41 | |||||
Inventory, 5 Yr. CAGR % | 9.02 | 11.39 | 14.98 | 16.63 | 16.34 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 82.68 | 90.16 | 90.5 | 54.01 | 46.39 | |||||
Total Assets, 5 Yr. CAGR % | 7.42 | 11.33 | 10.16 | 11.44 | 11.21 | |||||
Tangible Book Value, 5 Yr. CAGR % | 10.22 | 6.56 | 7.04 | 8.2 | 7.15 | |||||
Common Equity, 5 Yr. CAGR % | 6.05 | 7.03 | 7.59 | 8.53 | 8.19 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.2 | 20.13 | 11.18 | 16.84 | 26.68 | |||||
Capital Expenditures, 5 Yr. CAGR % | 107.25 | 63.98 | 25.08 | -3.22 | 16.76 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 14.79 | 3.41 | 0.58 | 56.61 | 12.79 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 13.57 | 1.44 | 2.34 | 60.73 | 13.66 | |||||
Dividend Per Share, 5 Yr. CAGR % | 22.44 | 20.31 | 21.13 | - | 25.19 |
- Stock Market
- Equities
- ITP Stock
- Financials Interparfums
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















